World's Best Scientists 2026 revealed!
Award Badge
Best Female Scientists
2025

D-Index & Metrics

Best Female Scientists

D-Index
108
Citations
56985
World Ranking
960
National Ranking
585

Medicine

D-Index
110
Citations
58777
World Ranking
5455
National Ranking
2938

Research.com Recognitions

  • 2025 - Research.com Best Female Scientists Award
  • 2017 - Fellow, National Academy of Inventors

Overview

Cheryl L. Willman is affiliated with the University of New Mexico in the United States. Their research is primarily situated within the field of Medicine, with a strong emphasis on Public Health, Environmental and Occupational Health, Hematology, Genetics, Cancer Research, and Pediatrics, Perinatology and Child Health.

Their scholarly work focuses notably on several key topics:

  • Acute Lymphoblastic Leukemia research
  • Cancer Genomics and Diagnostics
  • Acute Myeloid Leukemia Research
  • Childhood Cancer Survivors' Quality of Life
  • Advances in Oncology and Radiotherapy
  • Health and Medical Research Impacts
  • Chronic Myeloid Leukemia Treatments

Cheryl L. Willman has contributed to numerous publications, with notable recent papers including:

  • The genomic landscape of pediatric acute lymphoblastic leukemia, 2022, Nature Genetics
  • Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults, 2024, New England Journal of Medicine
  • Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL, 2021, Blood
  • Optimizing the Use of Telemedicine in Oncology Care: Postpandemic Opportunities, 2020, Clinical Cancer Research
  • Consolidation Therapy with Blinatumomab Improves Overall Survival in Newly Diagnosed Adult Patients with B-Lineage Acute Lymphoblastic Leukemia in Measurable Residual Disease Negative Remission: Results from the ECOG-ACRIN E1910 Randomized Phase III National Cooperative Clinical Trials Network Trial, 2022, Blood

Their work appears frequently in well-established scientific venues, including:

  • Blood
  • Journal of Clinical Oncology
  • Cancer Research
  • Cancer Epidemiology Biomarkers & Prevention
  • Clinical Cancer Research

Cheryl L. Willman has collaborated extensively with other researchers. The most frequent coauthors include:

  • Charles G. Mullighan
  • Brent L. Wood
  • Kathryn G. Roberts
  • Richard C. Harvey
  • Harry P. Erba

In recognition of their contributions, Cheryl L. Willman was named a Fellow of the National Academy of Inventors in 2017.

Best Publications

  • Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

    Bruce D. Cheson;John M. Bennett;Kenneth J. Kopecky;Thomas Büchner

  • Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study

    Marilyn L. Slovak;Kenneth J. Kopecky;Peter A. Cassileth;David H. Harrington

  • Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.

    Charles G Mullighan;Xiaoping Su;Jinghui Zhang;Ina Radtke

  • Age and acute myeloid leukemia

    Frederick R Appelbaum;Holly M Gundacker;David R Head;Marilyn L Slovak

  • Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia

    K. G. Roberts;Y. Li;D. Payne-Turner;R. C. Harvey

  • Langerhans'-cell histiocytosis (histiocytosis X)--a clonal proliferative disease.

    C L Willman;L Busque;B B Griffith;B E Favara

  • All-trans-Retinoic Acid in Acute Promyelocytic Leukemia

    Martin S. Tallman;Janet W. Andersen;Charles A. Schiffer;Frederick R. Appelbaum

  • Acute Myeloid Leukemia in the Elderly: Assessment of Multidrug Resistance (MDR1) and Cytogenetics Distinguishes Biologic Subgroups With Remarkably Distinct Responses to Standard Chemotherapy. A Southwest Oncology Group Study

    Catherine P. Leith;Kenneth J. Kopecky;John Godwin;Thomas McConnell

  • Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia

    W.-J. Song;M. G. Sullivan;R. D. Legare;S. Hutchings

  • The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers

    Carlee E. Ashley;Carlee E. Ashley;Eric C. Carnes;Genevieve K. Phillips;David P Padilla

  • Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction.

    K. E. Noonan;C. Beck;T. A. Holzmayer;J. E. Chin

  • The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia

    Yu Liu;John Easton;Ying Shao;Jamie Maciaszek

  • Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study.

    Michael J. Borowitz;Meenakshi Devidas;Stephen P. Hunger;W. Paul Bowman;W. Paul Bowman

  • Frequency and Clinical Significance of the Expression of the Multidrug Resistance Proteins MDR1/P-Glycoprotein, MRP1, and LRP in Acute Myeloid Leukemia. A Southwest Oncology Group Study

    Catherine P. Leith;Kenneth J. Kopecky;I-Ming Chen;Lisette Eijdems

  • Genetic Alterations Activating Kinase and Cytokine Receptor Signaling in High-Risk Acute Lymphoblastic Leukemia

    Kathryn G. Roberts;Ryan D. Morin;Jinghui Zhang;Martin Hirst

  • Chemotherapy Compared with Autologous or Allogeneic Bone Marrow Transplantation in the Management of Acute Myeloid Leukemia in First Remission

    Peter A. Cassileth;David P. Harrington;Frederick R. Appelbaum;Hillard M. Lazarus

  • Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia

    Richard C. Harvey;Richard C. Harvey;Charles G. Mullighan;I-Ming Chen;I-Ming Chen;Walker Wharton

  • JAK mutations in high-risk childhood acute lymphoblastic leukemia.

    Charles G. Mullighan;Jinghui Zhang;Richard C. Harvey;J. Racquel Collins-Underwood

  • Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia.

    Charles G Mullighan;J Racquel Collins-Underwood;Letha A A Phillips;Michael G Loudin

  • Gene expression changes associated with progression and response in chronic myeloid leukemia

    Jerald P. Radich;Hongyue Dai;Mao Mao;Vivian Oehler

Frequent Co-Authors

Stephen P. Hunger
Stephen P. Hunger University of Pennsylvania
William L. Carroll
William L. Carroll New York University
Meenakshi Devidas
Meenakshi Devidas St. Jude Children's Research Hospital
Frederick R. Appelbaum
Frederick R. Appelbaum Fred Hutchinson Cancer Research Center
Mignon L. Loh
Mignon L. Loh University of California, San Francisco
Charles G. Mullighan
Charles G. Mullighan St. Jude Children's Research Hospital
Naomi J. Winick
Naomi J. Winick The University of Texas Southwestern Medical Center
Michael J. Borowitz
Michael J. Borowitz Johns Hopkins University
Elizabeth A. Raetz
Elizabeth A. Raetz New York University
Andrew J. Carroll
Andrew J. Carroll University of Alabama at Birmingham

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Medicine students and professionals often explore online degree options that offer flexibility and career advancement. The growing demand for healthcare leaders has led many to pursue cahme accredited online mha programs, which focus on healthcare administration and management skills.

For registered nurses aiming to enhance their credentials without the commitment of in-person training, several online rn to bsn programs without clinicals provide a convenient path to earning a bachelor's degree in nursing.

Nurses seeking advanced clinical or leadership roles may consider doctoral options. Aspiring nurse practitioners can choose between 1 year dnp program online offerings for accelerated progression, or explore a variety of dnp programs tailored for working professionals.

These pathways support career growth and specialization, making it easier to balance study, work, and personal commitments while advancing in the healthcare field.

Best Scientists Citing Cheryl L. Willman

Trending Scientists

Recently Published Articles